Circadian rhythms regulated pulsatile drug delivery system
Keywords:
circadian rhythm, pulsatile, pulsatile technologies, time controlled pulsatile delivery, stimuli induced pulsatile delivery, externally regulated pulsatile drug deliveryAbstract
As the body works both day and night, genetics influences how effectively an organism adapts to a changing environment. During diseases, conditions like asthma, ulcers, and rheumatoid arthritis need treatment at certain times of the day. We require pulse drug delivery to avoid unwanted side effects depending on the disease condition. Its ability to prevent drug receptor downregulation and provide effective therapeutic effects has made pulsatile drug delivery a preferred method for treating diseases governed by the body's circadian cycle. The pulsatile release is used for drugs when a steady drug release (zero-order release) is undesirable. In time-controlled TCS systems, the delivery system controls the drug release. In stimulus-induced PDDS systems, the drug release is governed by stimulation factors like pH, temperature, and enzymes; external stimuli like magnetic, electric, and ultrasonic stimulation impact the drug release.The above-mentioned releasing mechanism is used by marketed technologies such as CODAS®, IPDAS®, etc. Pulsatile drug delivery systems are well suited for drugs with chronopharmacological characteristics and dose needs throughout the night.A pulsatile drug delivery system ensures that medications are administered to patients with chronic diseases such as asthma, hypertension, and rheumatoid arthritis at the right place, right time, right location, and the right dose.
Downloads
References
Abdul S, Poddar SS. A flexible technology for modified release of drugs: multi layered tablets. J Control release. 2004;97(3):393–405.
Albadri AA, Abdulbaqi MR, Almajidi YQ. Recent Trends in Chronopharmaceutics, Pulsatile Drug Delivery System. Al-Mustansiriyah J Pharm Sci. 2019;19(4):41–9.
Ali J, Baboota S, Ahuja A, Saigal N. Distinctive features of “chronotherapeutic” and “pulsatile” drug delivery systems negating the practice of their interchangeable terminology. J Drug Target. 2010;18(6):413–9.
ALOORKAR NH, SHINDE MB, SHIRKE SH, SABLE VU. Indian Journal of Novel Drug Delivery. Indian J Nov Drug Deliv. 2015;7(2):73–82.
Anal AK. Stimuli-induced pulsatile or triggered release delivery systems for bioactive compounds. Recent Pat Endocr Metab Immune Drug Discov. 2007;1(1):83–90.
Anal AK. Time-controlled pulsatile delivery systems for bioactive compounds. Recent Pat Drug Deliv Formul. 2007;1(1):73–9.
Anna W, Basel S. How to measure circadian rhythms in humans. Medicographia. 2007;29(1):84–90.
Arora S, Ali J, Ahuja A, Baboota S, Qureshi J. Pulsatile drug delivery systems: An approach for controlled drug delivery. Indian J Pharm Sci. 2006;68(3).
Belgamwar VS, Gaikwad M V, Patil GB, Surana S. Pulsatile drug delivery system. Asian J Pharm Free full text Artic from Asian J Pharm. 2008;2(3).
Bilaskar V V, Patil IS, Patil OA, Mandke GR, Mohite SK. Design, Development and Optimization of Pulsatile Drug Delivery of Antihypertensive Drug. 2018;
Bruguerolle B. Chronopharmacokinetics. Clin Pharmacokinet. 1998;35(2):83–94.
Bustamante-Torres M, Romero-Fierro D, Arcentales-Vera B, Palomino K, Magaña H, Bucio E. Hydrogels Classification According to the Physical or Chemical Interactions and as Stimuli-Sensitive Materials. Gels. 2021;7(4):182.
Chang H-C, Guarente L. SIRT1 mediates central circadian control in the SCN by a mechanism that decays with aging. Cell. 2013;153(7):1448–60.
Conte U, Maggi L. Modulation of the dissolution profiles from Geomatrix® multi-layer matrix tablets containing drugs of different solubility. Biomaterials. 1996;17(9):889–96.
Crison JR, Vieira ML, Kim JS, Siersma C, Amidon GL. Pulse delivery of methylphenidate in dogs using an osmotic drug delivery system. In: Proceed Intern Symp Control Rel Bioact Mater. 2001. p. 6101.
Dey N, Majumdar S, Rao M. Multiparticulate Drug Delivery Systems for Controlled Release. Trop J Pharm Res. 2008;7(3):1067–75.
Estevez, A. G., Espinosa, A. H. R., Rodríguez, D. L., & Leyva, T. F. (2019). Current approaches and controversies: legalization and non-legalization of drugs. International Journal of Health & Medical Sciences, 2(1), 26-32. https://doi.org/10.31295/ijhms.v2n1.85
Evans RM, Marain C. Taking your medication: A question of timing. Am Med Assoc. 1996;1996:3–8.
Flanner, Gastric release pulse system for drug delivery Abstract. US9125803B2, 2015.
Gothoskar A V, Joshi AM, Joshi NH. Pulsatile drug delivery systems: a review. Drug Deliv Technol. 2004;4(5):1–11.
Gupta NB. Pulsatile Drug Delivery as Modified Release Dosage Form: A Review. J drug Deliv Ther. 2012;2(6).
Gurny R, Junginger HE, Peppas NA. Pulsatile drug delivery(current applications and future trends). Paperb APV. 1993;
Huang R-C. The discoveries of molecular mechanisms for the circadian rhythm: The 2017 Nobel Prize in Physiology or Medicine. Biomed J. 2018;41(1):5–8.
Jain D, Raturi R, Jain V, Bansal P, Singh R. Recent technologies in pulsatile drug delivery systems. Biomatter. 2011;1(1):57–65.
Jaklenec, Micromolded or 3-D printed pulsatile release vaccine formulations. US10300136B2, 2019.
Jha N, Bapat S. Chronobiology and chronotherapeutics. Kathmandu Univ Med J. 2004;2(8):384–8.
Kalsbeek A, Palm IF, La Fleur SE, Scheer F, Perreau-Lenz S, Ruiter M, et al. SCN outputs and the hypothalamic balance of life. J Biol Rhythms. 2006;21(6):458–69.
Karale P, Diksha K, Pande V. Pros and cons of pulsatile drug delivery system. Int J Pharm Drug Anal. 2015;255–60.
Keeley, Pulsatile flux drug delivery. US8834446B2, 2014.
Kikuchi A, Okano T. Pulsatile drug release control using hydrogels. Adv Drug Deliv Rev. 2002;54(1):53–77.
Kost J. Ultrasound for controlled delivery of therapeutics. Clin Mater. 1993;13(1–4):155–61.
Kumar S, Jeet K, Baldi A. Recent technological advancements in multiparticulate formulations: The smart drug delivery systems. Asian J Pharm. 2015;9:S13-25.
Lalwani A, Santani DD. Pulsatile drug delivery systems. Indian J Pharm Sci. 2007;69(4):489.
Laposky AD, Bass J, Kohsaka A, Turek FW. Sleep and circadian rhythms: key components in the regulation of energy metabolism. FEBS Lett. 2008;582(1):142–51.
Leslie S. The Contin delivery system: Dosing considerations. J Allergy Clin Immunol. 1986;78(4):768–73.
Mali AD, Bathe RS. An updated review on pulsatile drug delivery system. Int J Adv Pharm. 2015;4(4):16–22.
Mandal AS, Biswas N, Karim KM, Guha A, Chatterjee S, Behera M, et al. Drug delivery system based on chronobiology—A review. J Control release. 2010;147(3):314–25.
Massin MM, Maeyns K, Withofs N, Ravet F, Gérard P. Circadian rhythm of heart rate and heart rate variability. Arch Dis Child. 2000;83(2):179–82.
Miyazaki S, Hou W, Takada M. Controlled drug release by ultrasound irradiation. Chem Pharm Bull. 1985;33(1):428–31.
Mohamad A, Dashevsky A. pH-independent pulsatile drug delivery system based on hard gelatin capsules and coated with aqueous dispersion Aquacoat® ECD. Eur J Pharm Biopharm. 2006;64(2):173–9.
MVV NR, Eaga C. Chronotherapeutics: An advanced approach to decrease the mortality in cardiovascular events. 2011;
Nagar M, Singhai S, Chopra VS, Gautam N, Trivedi P. Chronotropic systems; an emerging trend in drug delivery for pulsed release in chronopharmacotherapy. Int J Pharm Clin Res. 2010;2(1):10–9.
Pandit V, Kumar A, S Ashawat M, P Verma C, Kumar P. Recent advancement and technological aspects of pulsatile drug delivery system-a laconic review. Curr Drug Targets. 2017;18(10):1191–203.
Parmar RD, Parikh RK, Vidyasagar G, Patel D V, Patel CJ, Patel BD. Pulsatile drug delivery systems: an overview. Int J Pharm Sci Nanotechnol. 2009;2(3):605.
Patel VR, Patel VP. Pulsatile drug delivery system: a review. Int J Pharm Sci Res. 2015;6(9):3676–88.
Penhasi A, Gomberg M, Gomberg M. Specific time-delayed burst profile delivery system. Google Patents; 2011.
Percel, Pulsatile release histamine H2 antagonist dosage form. US6663888B2, 2003.
Pugh, Pulsatile release of medicaments from a punctal plug. US9125715B2, 2015.
Qureshi J, Amir M, Ahuja A, Baboota S, Ali J. Chronomodulated drug delivery system of salbutamol sulphate for the treatment of nocturnal asthma. Indian J Pharm Sci. 2008;70(3):351.
Rajput M, Sharma R, Kumar S, Jamil F, Sissodia N, Sharma S. Pulsatile drug delivery system: a review. Int J Res Pharm Biomed Sci. 2012;3(1):118–24.
Rasve G, Borade G, Deshmukh S, Tagalpallewar A. Pulsatile drug delivery system: current scenario. Int J Pharma Bio Sci. 2011;2(3):332–43.
Redfern P, Redfern PH. Chronotherapeutics. Pharmaceutical Press; 2003.
Roy P, Shahiwala A. Statistical optimization of ranitidine HCl floating pulsatile delivery system for chronotherapy of nocturnal acid breakthrough. Eur J Pharm Sci. 2009;37(3–4):363–9.
Sadaf muzaffar, Syed abdul azeez basha , Umm-e-hani M munawar ali tauqeer. Formulation and evaluation of pulsatile drug delivery system using meloxicam. Int J Pharm Anal Res. 2015;4(1):51–9.
Saigal N, Baboota S, Ahuja A, Ali J. Multiple-pulse drug delivery systems: setting a new paradigm for infectious disease therapy. Expert Opin Drug Deliv. 2009;6(4):441–52.
Saigal N, Baboota S, Ahuja A, Ali J. Site specific chronotherapeutic drug delivery systems: a patent review. Recent Pat Drug Deliv Formul. 2009;3(1):64–70.
Sarkhejiya NA, Bhardia PD. Newer insights into pulsatile drug delivery systems. World J Pharm Sci. 2017;134–50.
Schellekens, Ph-controlled pulsatile delivery system, methods for preparation and use thereof. EP1916995B1, 2015.
Servant A, Bussy C, Al-Jamal K, Kostarelos K. Design, engineering and structural integrity of electro-responsive carbon nanotube-based hydrogels for pulsatile drug release. J Mater Chem B. 2013;1(36):4593–600.
Sharma GS, Srikanth M V, Uhumwangho MU, Phani KSK, Ramana KVM. Recent trends in pulsatile drug delivery systems-A review. Int J drug Deliv. 2010;2(3).
Shidhaye S, Dhone A, Budhkar T, Surve C. Technologies in pulsatile drug delivery system. Int J Adv pharmacy, Biol Chem. 2012;1(4):438–42.
Smolensky MH, Peppas NA. Chronobiology, drug delivery, and chronotherapeutics. Adv Drug Deliv Rev. 2007;59(9–10):828–51.
Solanki AJ, Jaiswal JJ, Yadav SK. A recent approach on pulsatile drug delivery system. J Pharm Sci Biosci Res. 2016;6:231–8.
Spencer TJ, Bonab AA, Dougherty DD, Mirto T, Martin J, Clarke A, et al. Understanding the central pharmacokinetics of spheroidal oral drug absorption system (SODAS) dexmethylphenidate: A positron emission tomography study of dopamine transporter receptor occupancy measured with C-11 altropane. J Clin Psychiatry. 2011;72(3):21838.
Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2022). Post-pandemic health and its sustainability: Educational situation. International Journal of Health Sciences, 6(1), i-v. https://doi.org/10.53730/ijhs.v6n1.5949
Thitinan S, McConville JT. Development of a gastroretentive pulsatile drug delivery platform. J Pharm Pharmacol. 2012;64(4):505–16.
Traitel T, Cohen Y, Kost J. Characterization of glucose-sensitive insulin release systems in simulated in vivo conditions. Biomaterials. 2000;21(16):1679–87.
Ura J, Shirachi D, Ferrill M. The chronotherapeutic approach to pharmaceutical treatment. Calif Pharm. 1992;23(9):46–53.
Vaka, Programmable pharmaceutical compositions for chrono drug release. US11154494B2, 2021.
Venkatesh G. Diffucaps® technology for controlled release drug delivery. Chronother Sci Technol Biol Rhythm Ther Prev Dis John Wiley Sons, Inc, New York. 2009;121–44.
Venkatesh, Timed, pulsatile release systems. US9566249B2, 2017.
Venketesh G. New tools for timed, pulsatile drug delivery. Pharma Formu Qual. 2005;
Washington N, Washington C, Wilson C. Physiological pharmaceutics: barriers to drug absorption. CRC Press; 2000.
Weiner, Pulsatile peri-corneal drug delivery device. US8469934B2, 2013.
Wells CM, Harris M, Choi L, Murali VP, Guerra FD, Jennings JA. Stimuli-responsive drug release from smart polymers. J Funct Biomater. 2019;10(3):34.
Xie Y, Tang Q, Chen G, Xie M, Yu S, Zhao J, et al. New insights into the circadian rhythm and its related diseases. Front Physiol. 2019;10(JUN):1–19.
Youan B-BC. Chronopharmaceutics: science and technology for biological rhythm guided therapy and prevention of diseases. John Wiley & Sons; 2009.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
